McCormick & Company
MKC
$52.28
-0.49%
McCormick & Company is the world's leading manufacturer of spices, herbs, extracts, seasonings, and other flavorings, operating primarily in the packaged foods industry. Its portfolio includes iconic brands such as Old Bay, French's, Frank's RedHot, and Cholula, and it serves both consumer and commercial (Flavor Solutions) customers. The company is currently at the center of a transformative $45 billion acquisition of Unilever's food business, which would add Knorr and Hellmann's to its portfolio and significantly expand its scale and emerging market presence. Investors are sharply divided on the deal, with concerns about dilution, debt, and integration risks weighing on the stock, which has fallen to multi-year lows despite solid underlying fundamentals.…
MKC
McCormick & Company
$52.28
Related headlines
Investment Opinion: Should I buy MKC Today?
We rate MKC a Buy, driven by the compelling risk/reward at current levels. The stock trades at a forward PE of 15.4x, a 14% discount to the industry average, and offers 19.1% upside to the average analyst target of $60.62. Revenue growth accelerated to 16.7% YoY in Q2 2026, and gross margins expanded to 40.2%, indicating strong operational execution. Free cash flow of $1.16B supports the dividend (yield 2.7%) and debt servicing, while the consensus Buy rating from 13 analysts reinforces our view.
Sign up to view all
MKC 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The company's strong operational performance is offset by the significant risks of the Unilever deal. The forward valuation is attractive, but the market's skepticism is justified given the execution challenges. If the deal closes and synergies materialize, the stock could re-rate higher; conversely, any misstep could lead to further downside. We would upgrade to bullish on evidence of successful integration and margin expansion, and downgrade to bearish if the deal fails or debt levels become unsustainable.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on McCormick & Company's 12-month outlook, with a consensus price target around $60.62 and implied upside of +15.9% versus the current price.
Average Target
$60.62
0 analysts
Implied Upside
+15.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$52 - $75
Analyst target range
McCormick is covered by 13 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 2.13 (where 1 is Strong Buy and 5 is Sell). The average price target is $60.62, implying an upside of 19.1% from the current price of $50.90. The target range is wide, from a low of $52.00 to a high of $75.00, reflecting high uncertainty about the outcome of the Unilever deal. The high target of $75 assumes successful integration and significant synergies, while the low target of $52 suggests that the deal could be dilutive or face execution issues. Recent ratings from major firms have been mostly positive, with Barclays and UBS maintaining Neutral/Equal Weight, while Bernstein, TD Cowen, and Deutsche Bank have Buy/Outperform ratings, indicating a cautiously optimistic stance.
Drowning in data?
Find the real signal!
Bulls vs Bears: MKC Investment Factors
McCormick presents a classic high-risk, high-reward scenario. The bull case rests on strong underlying fundamentals—accelerating revenue growth, margin expansion, and a forward PE discount—while the bear case centers on the transformative but risky Unilever acquisition, which has already caused a 28% stock decline and a 41% max drawdown. The most critical tension is whether the deal's synergies and growth potential will outweigh the debt, dilution, and integration risks. Currently, the bearish sentiment dominates the price action, but the analyst consensus and forward valuation suggest the market may be overly pessimistic. The evidence slightly favors the bulls on a 12-month horizon, assuming successful integration and synergy realization.
Bullish
- Accelerating Revenue Growth: Q2 2026 revenue grew 16.7% YoY to $1.94B, up from 8.4% growth in the prior quarter, indicating strong momentum in both consumer and Flavor Solutions segments.
- Margin Expansion: Gross margin improved to 40.2% in Q2 2026 from 37.5% a year ago, driven by pricing actions and cost savings, supporting profitability despite higher interest costs.
- Attractive Forward Valuation: Forward PE of 15.4x is a 14% discount to the industry average of 18x, suggesting the market is pricing in significant earnings growth from the Unilever deal.
- Analyst Consensus Buy: With 13 analysts, the consensus is Buy (mean score 2.13) and the average price target of $60.62 implies 19.1% upside from the current price of $50.90.
Bearish
- Massive Debt and Dilution: The $45B Unilever deal will significantly increase debt and dilute existing shareholders, as evidenced by the stock's 27.9% decline over the past year and 41.2% max drawdown.
- Integration Risk: Integrating Unilever's food business (Knorr, Hellmann's) is complex and could face execution issues, as highlighted by the wide analyst target range ($52-$75) reflecting high uncertainty.
- Margin Compression from Interest: Net margin fell to 8.3% in Q2 2026 from 10.5% a year ago, due to higher interest expenses ($62.7M in Q2) and one-time costs, which could persist post-deal.
- Negative Relative Strength: The stock underperformed the S&P 500 by 46.1% over the past year, with a beta of 0.63, indicating persistent selling pressure and weak momentum.
MKC Technical Analysis
McCormick's stock is in a pronounced downtrend, with a 1-year price change of -27.93% and a 6-month change of -17.68%. The current price of $50.90 sits just 13.5% above its 52-week low of $44.82 and 29.9% below its 52-week high of $72.58, indicating that the stock is trading near the bottom of its range. This positioning suggests that the market is pricing in significant negative sentiment, likely related to the Unilever acquisition, and that the stock may be approaching oversold levels, though the trend remains firmly bearish.
Beta
0.63
0.63x market volatility
Max Drawdown
-40.4%
Largest decline past year
52-Week Range
$45-$73
Price range past year
Annual Return
-24.7%
Cumulative gain past year
| Period | MKC Return | S&P 500 |
|---|---|---|
| 1m | +0.1% | +2.8% |
| 3m | +8.2% | +4.2% |
| 6m | -22.5% | +11.3% |
| 1y | -24.7% | +21.5% |
| ytd | -22.3% | +12.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MKC Fundamental Analysis
McCormick's revenue growth has been robust, with the most recent quarter (Q2 2026) showing revenue of $1.94 billion, a 16.7% year-over-year increase, accelerating from the prior quarter's 8.4% growth. The company's gross margin improved to 40.2% in Q2 2026, up from 37.5% in the year-ago quarter, reflecting pricing actions and cost savings. Net income for the quarter was $160.2 million, with a net margin of 8.3%, down from 10.5% in Q2 2025, due to higher interest expenses and one-time costs related to the acquisition. The company's balance sheet shows a debt-to-equity ratio of 0.70, and free cash flow for the trailing twelve months was $1.16 billion, providing some cushion for the increased leverage expected from the Unilever deal.
Quarterly Revenue
$1.9B
2026-05
Revenue YoY Growth
+16.7%
YoY Comparison
Gross Margin
40.2%
Latest Quarter
Free Cash Flow
$1.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MKC Overvalued?
Given that McCormick is profitable, the price-to-earnings (PE) ratio is the most appropriate valuation metric. The trailing PE stands at 22.6x, while the forward PE is 15.4x, implying that the market expects significant earnings growth, likely from the Unilever acquisition. Compared to the industry average PE of 18x (based on available data), McCormick trades at a 25% premium on a trailing basis, but at a 14% discount on a forward basis, suggesting that the market is pricing in the deal's potential synergies. Historically, McCormick's PE has ranged from 20x to 35x over the past two years, and the current trailing PE of 22.6x is near the lower end of that range, indicating that the stock is relatively cheap compared to its own history, though the forward PE suggests the market is already anticipating a recovery.
PE
22.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 20x~41x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are elevated due to the pending $45B Unilever acquisition. The company's debt-to-equity ratio is already 0.70, and the deal will likely increase leverage substantially, raising interest expenses (already $62.7M in Q2 2026) and pressuring net margins, which fell to 8.3% from 10.5% a year ago. Free cash flow of $1.16B provides some cushion, but the current ratio of 0.70 indicates potential liquidity strain. Revenue concentration in spices and flavorings is being diversified, but the integration of Unilever's food business carries execution risk that could lead to cost overruns and operational disruptions.
FAQ
The primary risks are financial, competitive, macro, and company-specific. Financially, the $45B Unilever deal increases debt and interest expenses, which could pressure margins (net margin already fell to 8.3% in Q2 2026). Competitively, the packaged foods industry is mature, and MKC faces competition from private labels and other brands. Macro risks include inflation and consumer spending shifts, though MKC's beta of 0.63 suggests lower market sensitivity. Company-specific risks include integration failure, regulatory hurdles, and execution issues, which could lead to a decline toward the 52-week low of $44.82.
The 12-month forecast is mixed, with a base case (45% probability) targeting $55-$65, a bull case (30%) targeting $65-$75, and a bear case (25%) targeting $44-$52. The base case assumes successful deal closure with moderate synergies, while the bull case assumes faster-than-expected integration and strong growth. The bear case reflects deal failure or integration problems. The most likely scenario is the base case, with the stock reaching the average analyst target of $60.62, implying 19.1% upside.
On a trailing basis, MKC trades at 22.6x PE, a 25% premium to the industry average of 18x, but on a forward basis, it's at 15.4x, a 14% discount. This suggests the market is pricing in significant earnings growth from the Unilever deal. Historically, the stock's PE has ranged from 20x to 35x, so the current trailing PE is near the lower end, indicating it's relatively cheap compared to its own history. The forward discount implies the market expects the deal to be accretive, but the wide analyst target range reflects uncertainty.
MKC offers a compelling risk/reward at current levels, with a forward PE of 15.4x (14% below industry) and 19.1% upside to the average analyst target of $60.62. The main downside risk is the $45B Unilever acquisition, which could lead to debt and integration issues. For investors with a long-term horizon and tolerance for volatility, it could be a good buy, especially if the deal closes successfully. However, those with low risk tolerance may prefer to wait for more clarity on the deal's outcome.
MKC is better suited for long-term investment due to its defensive nature, dividend yield of 2.7%, and potential for growth from the Unilever deal. The stock's beta of 0.63 indicates lower volatility than the market, making it a stable holding. However, the near-term uncertainty around the deal could cause price swings, so short-term traders might find opportunities, but the risk is elevated. A minimum holding period of 3-5 years is recommended to allow the deal's benefits to materialize and the stock to re-rate.
